Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Elanco Animal Health IncELAN · Entity 3457 | Director · PRESIDENT, CEO AND DIRECTOR | October 02, 2026 | October 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Elanco Animal Health Inc
Report date October 02, 2026 · Filed October 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 25,499.2826 |
Reported balance
After 2026-10-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-10-02 · Grant · Acquired 127.6843 · Balance 25,499.2826 F1: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
F2: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ELI LILLY & Co
Report date December 31, 2018 · Filed February 01, 2019
Section 16 reporting ended · disclosed 2019-02-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 132,258 |
Reported balance
After 2018-03-13 transaction · row 1
1 source rowRow 1 · 2018-03-13 · Gift · Disposed 3,200 · Balance 132,258 |
| Common StockSEC Table I · non-derivative | Indirect401(k) | 1,093 |
Reported balance
Holding disclosure · report date 2018-12-31 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,093 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 31, 2016 Filed Sep 1, 2016 19:58 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 6,556 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000416 · wf-form4_147275990864052.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,546 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2016 Filed Jan 27, 2017 17:16 UTC | ELI LILLY & Co LLY · Entity 2794 | GiftCommon Stock | 4,450 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000017 · wf-form5_148553737544063.xml · nonDerivative · entry 2 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,958 Read SEC document |
| March 24, 2016 Filed Jan 27, 2017 17:16 UTC | ELI LILLY & Co LLY · Entity 2794 | GiftCommon Stock | 2,105 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000017 · wf-form5_148553737544063.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,408 Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 19:06 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 9,843 | $79.10 | $778,581.30 |
DisclosureSEC source: 0000059478-16-000310 · wf-form4_145452637957902.xml · derivative · entry 4 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,843 shares Expires 2016-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 19:06 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 4,553 | $79.10 | $360,142.30 |
DisclosureSEC source: 0000059478-16-000310 · wf-form4_145452637957902.xml · nonDerivative · entry 2 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,990 Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 19:06 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 9,843 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000310 · wf-form4_145452637957902.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,543 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 26, 2016 Filed Jan 28, 2016 23:46 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 10,244 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000270 · wf-form4_145402475570550.xml · derivative · entry 3 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,244 Underlying: Common Stock · 10,244 shares Expires 2017-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| January 26, 2016 Filed Jan 28, 2016 23:46 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 19,344 | $81.96 | $1,585,434.24 |
DisclosureSEC source: 0000059478-16-000270 · wf-form4_145402475570550.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,700 Read SEC document |
| June 04, 2015 Filed Jan 25, 2016 20:54 UTC | ELI LILLY & Co LLY · Entity 2794 | GiftCommon Stock | 4,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000247 · wf-form5_145375523700477.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,356 Read SEC document |
| May 29, 2015 Filed Jun 1, 2015 20:31 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 20,000 | $78.08 | $1,561,600.00 |
DisclosureSEC source: 0000059478-15-000149 · wf-form4_143319067763029.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,856 F1 · price: This transaction was executed in multiple trades at prices ranging from $78.01 to $78.25. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 01, 2015 Filed Feb 3, 2015 21:11 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 12,591 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-15-000068 · wf-form4_142299786163667.xml · derivative · entry 4 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,591 shares Expires 2015-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2015 Filed Feb 3, 2015 21:11 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 5,824 | $72.00 | $419,328.00 |
DisclosureSEC source: 0000059478-15-000068 · wf-form4_142299786163667.xml · nonDerivative · entry 2 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,856 Read SEC document |
| February 01, 2015 Filed Feb 3, 2015 21:11 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 12,591 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-15-000068 · wf-form4_142299786163667.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,680 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 28, 2015 Filed Jan 30, 2015 22:45 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 9,843 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-15-000040 · wf-form4_142265788981247.xml · derivative · entry 3 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,843 Underlying: Common Stock · 9,843 shares Expires 2016-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| January 28, 2015 Filed Jan 30, 2015 22:45 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 27,653 | $70.97 | $1,962,533.41 |
DisclosureSEC source: 0000059478-15-000040 · wf-form4_142265788981247.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,089 Read SEC document |
| November 19, 2014 Filed Nov 21, 2014 15:52 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionEmployee stock option 2/06 (right to buy) · Derivative | 9,789 | $0.00 Strike: $56.18 | $0.00 |
DisclosureSEC source: 0000059478-14-000189 · wf-form4_141658514859976.xml · derivative · entry 7 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,789 shares Expires 2016-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2014 Filed Nov 21, 2014 15:52 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionEmployee stock option 2/05 (right to buy) · Derivative | 8,787 | $0.00 Strike: $55.65 | $0.00 |
DisclosureSEC source: 0000059478-14-000189 · wf-form4_141658514859976.xml · derivative · entry 6 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,787 shares Expires 2015-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2014 Filed Nov 21, 2014 15:52 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 8,752 | $67.78 | $593,210.56 |
DisclosureSEC source: 0000059478-14-000189 · wf-form4_141658514859976.xml · nonDerivative · entry 4 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,436 Read SEC document |
| November 19, 2014 Filed Nov 21, 2014 15:52 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 9,789 | $56.18 | $549,946.02 |
DisclosureSEC source: 0000059478-14-000189 · wf-form4_141658514859976.xml · nonDerivative · entry 3 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,188 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2014 Filed Nov 21, 2014 15:52 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 7,796 | $67.78 | $528,412.88 |
DisclosureSEC source: 0000059478-14-000189 · wf-form4_141658514859976.xml · nonDerivative · entry 2 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,399 Read SEC document |
| November 19, 2014 Filed Nov 21, 2014 15:52 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 8,787 | $55.65 | $488,996.55 |
DisclosureSEC source: 0000059478-14-000189 · wf-form4_141658514859976.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,195 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2014 Filed Feb 4, 2014 15:27 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 9,405 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-14-000065 · wf-form4_139152766608504.xml · derivative · entry 4 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,405 shares Expires 2014-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2014 Filed Feb 4, 2014 15:27 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 4,360 | $54.01 | $235,483.60 |
DisclosureSEC source: 0000059478-14-000065 · wf-form4_139152766608504.xml · nonDerivative · entry 2 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,408 Read SEC document |
| February 01, 2014 Filed Feb 4, 2014 15:27 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 9,405 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-14-000065 · wf-form4_139152766608504.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,768 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 28, 2014 Filed Jan 31, 2014 01:31 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 12,591 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-14-000033 · wf-form4_139113185427982.xml · derivative · entry 3 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,591 Underlying: Common Stock · 12,591 shares Expires 2015-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| January 28, 2014 Filed Jan 31, 2014 01:31 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 20,613 | $54.23 | $1,117,842.99 |
DisclosureSEC source: 0000059478-14-000033 · wf-form4_139113185427982.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,363 Read SEC document |
| May 10, 2013 Filed May 13, 2013 19:37 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 10,000 | $54.49 | $544,900.00 |
DisclosureSEC source: 0001209191-13-025785 · doc4.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres.,Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,750 F1 · price: This transaction was executed in multiple trades at prices ranging from $54.49 to $54.51. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 01, 2013 Filed May 1, 2013 19:44 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 10,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-13-023300 · doc4.xml · derivative · entry 4 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres.,Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2013-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2013 Filed May 1, 2013 19:44 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 4,635 | $55.38 | $256,686.30 |
DisclosureSEC source: 0001209191-13-023300 · doc4.xml · nonDerivative · entry 2 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres.,Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,750 Read SEC document |
| May 01, 2013 Filed May 1, 2013 19:44 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-13-023300 · doc4.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres.,Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,385 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2013 Filed Feb 4, 2013 21:31 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 17,649 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-13-005997 · doc4.xml · derivative · entry 4 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres.,Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,649 shares Expires 2013-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2013 Filed Feb 4, 2013 21:31 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 8,181 | $53.69 | $439,237.89 |
DisclosureSEC source: 0001209191-13-005997 · doc4.xml · nonDerivative · entry 2 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres.,Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,385 Read SEC document |
| February 01, 2013 Filed Feb 4, 2013 21:31 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 17,649 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-13-005997 · doc4.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres.,Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,566 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 25, 2013 Filed Jan 29, 2013 21:56 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 9,405 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-13-005004 · doc4.xml · derivative · entry 3 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres.,Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,405 Underlying: Common Stock · 9,405 shares Expires 2014-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| January 25, 2013 Filed Jan 29, 2013 21:56 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 19,735 | $53.21 | $1,050,099.35 |
DisclosureSEC source: 0001209191-13-005004 · doc4.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres.,Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,917 Read SEC document |
| February 13, 2012 Filed Feb 15, 2012 17:08 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 7,900 | $38.85 | $306,915.00 |
DisclosureSEC source: 0001209191-12-010305 · doc4.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres.,Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,182 Read SEC document |
| January 26, 2012 Filed Jan 30, 2012 22:51 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 17,649 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-006154 · doc4.xml · derivative · entry 3 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres.,Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,649 Underlying: Common Stock · 17,649 shares Expires 2013-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| January 26, 2012 Filed Jan 30, 2012 22:51 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 4,686 | $39.44 | $184,815.84 |
DisclosureSEC source: 0001209191-12-006154 · doc4.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres.,Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,082 Read SEC document |
| August 31, 2011 Filed Sep 1, 2011 18:06 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 3,278 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-046262 · doc4.xml · derivative · entry 4 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres.,Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,278 shares Expires 2011-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 31, 2011 Filed Sep 1, 2011 18:06 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 3,278 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-046262 · doc4.xml · nonDerivative · entry 2 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres.,Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,056 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 31, 2011 Filed Sep 1, 2011 18:06 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 1,340 | $37.17 | $49,807.80 |
DisclosureSEC source: 0001209191-11-046262 · doc4.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres.,Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,778 Read SEC document |
| January 25, 2011 Filed Jan 27, 2011 23:07 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 15,694 | $34.73 | $545,052.62 |
DisclosureSEC source: 0001209191-11-005332 · doc4.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres.,Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,458 Read SEC document |
| January 26, 2010 Filed Jan 28, 2010 23:27 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 12,595 | $36.16 | $455,435.20 |
DisclosureSEC source: 0001209191-10-005360 · doc4.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · President-Elanco Anml.Hlth. BU 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,764 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.